Updates and news related to prostate cancer:
Chronic disease and COVID-19
What you need to know: tips and information to protect yourself and your family
Self care and stress management during the COVID-19 crisis
Tips from the toolkit for oncology health care professionals
The latest in prostate cancer research
Seven takeaways from a community symposium highlighting recent advances in prevention, screening and treatment
New, non-hormonal target identified for advanced prostate cancer
Hormone therapies for advanced prostate cancer have greatly prolonged the lives of patients
Breaking News: FDA approves enzalutamide for metastatic castration- sensitive prostate cancer
Enzalutamide has previously been FDA-approved for treatment of metastatic castration-resistant prostate cancer (mCRCP) and non-metastatic castration-resistant prostate cancer (nmCRPC).
Home urine test could ‘revolutionize diagnosis’
A new pilot study concludes that at-home urine tests could make prostate cancer diagnosis shorter, simpler, and possibly even more accurate.
New technology uses ultrasound to kill prostate cancer with no surgery and 80% success rate
After treatment, 65 percent of men in study had no signs of cancer after one year.
Destroying prostate cancer with novel noninvasive MRI guided ultrasound treatment
By Radiological Society of North America, December 2, 2019
More treatment options emerging for some with metastatic prostate cancer
The treatment landscape for metastatic prostate cancer is shifting and expanding yet again, according to new findings from two large clinical trials presented at the American Society of Clinical Oncology.
High levels of two hormones in the blood increase prostate cancer risk
Some men are more likely to be diagnosed with prostate cancer depending on two factors, according to research presented at the 2019 National Cancer Research Institute Conference.